【摘要】 目的　探讨蝮蛇抗栓酶治疗重度黄疸肝炎的疗效。方法　 2 6 8例重度黄疸肝炎 (TBiL≥ 170 1μmol/L ,PTA≥ 4 0 % )病人分治疗组 (136例 )和对照组 (132例 ) ,在同样对症治疗的基础上 ,治疗组加用蝮蛇抗栓酶 0 5～ 0 75U静滴 ,4周为 1个疗程。结果　治疗组治愈、显效及总有效率高于对照组 (P <0 0 5 )。治疗组的降黄效果亦好于对照组 (P <0 0 5 )。结论　蝮蛇抗栓酶对重度黄疸肝炎有良好的疗效。更多还原

【Abstract】 Objective To explore the effect of agkistrodon halys anti-embolism enzyme on severe icteric hepatitis.Methods There were 268 patients with severe icteric hepatitis(TBiL≥170.1μmol/L,PTA≥40%) who were divided into the treating group(136 cases) and the control group(132 cases).On the basis of the same symptomatic therapy,the treating group added the agkistrodon halys anti-embolism enzyme(0.5～0.75U) intraveinously.One therapy course was four weeks.Results The effective rates in the treating group were higher than those in control group(P<0.05).The abating icterus effect in the treating group were better than that in control group(P<0.05).Conclusion Agkistrodon halys anti-embolism enzyme has significant effect to the severe icteric hepatitis.更多还原